-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Arrowhead Pharma, Raises Price Target to $81

Benzinga·01/07/2026 15:28:11
語音播報
Morgan Stanley analyst Michael Ulz maintains Arrowhead Pharma (NASDAQ:ARWR) with a Equal-Weight and raises the price target from $48 to $81.